Answer
Xultophy is injected only subcutaneously in the thigh, upper arm or abdomen, rotating injection sites within the same region to reduce lipodystrophy and cutaneous amyloidosis risk; it must not be injected intravenously or intramuscularly.
Sources for this answer
- Xultophy 100 units/mL + 3.6 mg/mL solution for injectionNovo Nordisk Limited · emc · SmPC §4.2 Posology and method of administration · Version 6Document updated
Sources checked